Hematopoietic Neoplasms (DBCOND0118916)

Identifiers

Synonyms

Hematopoietic Neoplasm / Haematopoietic neoplasm / Malignant hematopoietic neoplasm (morphologic abnormality) / Haematopoietic neoplasm NOS / Hematopoietic neoplasm (morphologic abnormality)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04951323	Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)	Tozinameran	prevention	3	unknown_status
NCT06010017	Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation	No drug interventions	supportive_care	Not Available	recruiting
NCT06587100	Wearable Activity Tracking to Curb Hospitalizations	No drug interventions	Not Available	Not Available	not_yet_recruiting
NCT01437787	Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis	Fedratinib	treatment	3	completed
NCT01420783	Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia	Fedratinib	treatment	2	completed
NCT04622956	GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide	Methotrexate	prevention	1 / 2	recruiting
NCT03377010	UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in HSCT Survivors	No drug interventions	Not Available	Not Available	completed
NCT01523171	Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib	Fedratinib	treatment	2	completed
NCT05759975	Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCT	No drug interventions	prevention	Not Available	recruiting
NCT01420770	Phase 2 Study of SAR302503 in Patients With Myelofibrosis	Fedratinib	treatment	2	completed